Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Daiichi Sankyo
McKinsey
AstraZeneca
Express Scripts

Generated: March 20, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Roniciclib

« Back to Dashboard

US Patents for Roniciclib

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Roniciclib ➤ Try a Free Trial Human papilloma virus as predictor of cancer prognosis Foundation Medicine, Inc. (Cambridge, MA) UCL Business PLC (London, GB) ➤ Try a Free Trial
Roniciclib ➤ Try a Free Trial Sulfoximine-substituted anilinopyrimidine derivatives as CDK inhibitors, the production thereof, and use as medicine Bayer Intellectual Property GmbH (Monheim, DE) ➤ Try a Free Trial
Roniciclib ➤ Try a Free Trial Process for preparing pan-CDK inhibitors of the formula (I), and intermediates in the preparation Bayer Intellectual Property GmbH (Monheim, DE) ➤ Try a Free Trial
Roniciclib ➤ Try a Free Trial Human papilloma virus as predictor of cancer prognosis FOUNDATION MEDICINE, INC. (Cambridge, MA) UCL Business PLC (London, GB) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Roniciclib

Drugname Country Document Number Estimated Expiration Related US Patent
Roniciclib Australia 2013296237 2032-08-03 ➤ Try a Free Trial
Roniciclib Canada 2880764 2032-08-03 ➤ Try a Free Trial
Roniciclib European Patent Office 2880448 2032-08-03 ➤ Try a Free Trial
Roniciclib Hong Kong 1213044 2032-08-03 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Colorcon
Mallinckrodt
Chubb
Merck
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.